The aim of this study was to evaluate the association between rs1107946 and rs1800012 polymorphisms in COL1A1, as well as rs42524 in COL1A2, with BMD and the risk of metabolic disorders in postmenopausal women. The gene discussed is COL1A2; the disease is metabolic disease.